In the Weeds: Nation's First Guidelines for Management of Perioperative Patients on Cannabis

The Pulse| March 2024 In the Weeds: Nation's First Guidelines for Management of Perioperative Patients on Cannabis Kim Sumrak Kim Sumrak Search for other works by this author on: This Site PubMed Google Scholar ASA Monitor March 2024, Vol. 88, 30–33. https://doi.org/10.1097/01.ASM.0001008300.88901.d7 Views Icon Views Article contents Figures & tables Video Audio Supplementary Data Peer Review Share Icon Share Facebook Twitter LinkedIn Email Cite Icon Cite Get Permissions Search Site Citation Kim Sumrak; In the Weeds: Nation's First Guidelines for Management of Perioperative Patients on Cannabis. ASA Monitor 2024; 88:30–33 doi: https://doi.org/10.1097/01.ASM.0001008300.88901.d7 Download citation file: Ris (Zotero) Reference Manager EasyBib Bookends Mendeley Papers EndNote RefWorks BibTex toolbar search Search Dropdown Menu toolbar search search input Search input auto suggest filter your search All ContentAll PublicationsASA Monitor Search Advanced Search Topics: cannabis, guidelines, marijuana, perioperative care Whether due to legalization, culture change, or other reasons, Americans have been using more cannabis over the past 20 years. According to the U.S. Substance Abuse and Mental Health Services Administration, it's the most commonly used recreational drug in the U.S., with about 10% of Americans reporting monthly use in 2018 (asamonitor.pub/33PVpbL). It ranks second only to alcohol as the most common psychotropic substance. While it may be years until there's clear consensus on the health implications of cannabis, some in the anesthesiology community have concerns that it could potentially interact with anesthesia and lead to surgical complications. Addressing the ambiguity on how to manage these patients, the American Society of Regional Anesthesia and Pain Medicine (ASRA Pain Medicine) charged a special task force to develop guidelines for the perioperative use of cannabis in November 2020. The Perioperative Use of Cannabis and Cannabinoids Guidelines Committee, composed of 13... You do not currently have access to this content.